See enclosed pdf.
Comments on rumours in the market
Coloplast confirm that we have reached a settlement agreement in principle with a group of lawyers on a number of claims against the company. The settlement agreement concerns product liability insurance claims in USA on the use of mesh for treatment of pelvic organic prolapse and stress urinary incontinence.
| Source: Coloplast A/S
Recommended Reading
-
The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be...
Read More -
2025/26Interim financial results, H1 2025/261 October 2025 - 31 March 2026 Coloplast delivered Q2 organic growth of 6% and 6% EBIT growth1 in constant currencies. Strong quarter in Chronic Care and...
Read More